Literature DB >> 9666525

Forearm blood flow measured by venous occlusion plethysmography in healthy subjects and in women with postmastectomy oedema.

A W Stanton1, B Holroyd, J W Northfield, J R Levick, P S Mortimer.   

Abstract

A chronic swelling of the arm may develop following damage to axillary lymph vessels during breast cancer treatment. Certain unusual pathophysiological features of postmastectomy oedema indicate that factors additional to lymphatic damage are important. One factor postulated previously is a haemodynamic abnormality. Forearm blood flow was therefore measured by venous occlusion plethysmography using both a conventional mercury strain gauge and a newer optical volumeter (Perometer). The latter was initially assessed in healthy subjects. When forearm blood flow was measured using the two methods simultaneously, the strain gauge and Perometer did not differ significantly for healthy or oedematous arms. Dominant and non-dominant arm blood flow in healthy subjects was similar but with greater variation between sides with the Perometer. Using the strain gauge, blood flow in the oedematous arm (2.51 +/- 1.33 ml/100 ml per min) was significantly lower than in the opposite unaffected arm (3.77 +/- 2.29 ml/100 ml per min; p = 0.026). The Perometer results showed a similar but nonsignificant trend (p = 0.105). Taking into account the greater limb volume on the affected side, total forearm blood flow was essentially the same in each arm (unaffected: 40.72 +/- 28.70 micromilligrams/min; oedematous: 41.78 +/- 22.11 ml/min). The reduced blood flow per unit volume of arm was therefore likely to be due to a simple 'dilution' effect of the increase in volume. The results indicate that it is unlikely that raised blood flow contributes to oedema formation, contrary to the haemodynamic concept.

Entities:  

Mesh:

Year:  1998        PMID: 9666525     DOI: 10.1177/1358836X9800300102

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  6 in total

1.  Segmental blood flow and hemodynamic state of lymphedematous and nonlymphedematous arms.

Authors:  Leslie D Montgomery; Mary S Dietrich; Jane M Armer; B R Stewart; Sheila H Ridner
Journal:  Lymphat Res Biol       Date:  2011-03       Impact factor: 2.589

2.  Sympathetic nerve damage as a potential cause of lymphoedema after axillary dissection for breast cancer.

Authors:  T M Bennett Britton; S M L Wallace; I B Wilkinson; P S Mortimer; A M Peters; A D Purushotham
Journal:  Br J Surg       Date:  2009-08       Impact factor: 6.939

3.  Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity.

Authors:  Kristen J Nadeau; Phillip S Zeitler; Timothy A Bauer; Mark S Brown; Jennifer L Dorosz; Boris Draznin; Jane E B Reusch; Judith G Regensteiner
Journal:  J Clin Endocrinol Metab       Date:  2009-07-07       Impact factor: 5.958

4.  A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.

Authors:  Nadia Saucedo-Zeni; Steffi Mewes; Robert Niestroj; Lukasz Gasiorowski; David Murawa; Piotr Nowaczyk; Tatiana Tomasi; Ekkehard Weber; Grzegorz Dworacki; Nils G Morgenthaler; Heike Jansen; Corinna Propping; Karolina Sterzynska; Wojciech Dyszkiewicz; Maciej Zabel; Marion Kiechle; Ute Reuning; Manfred Schmitt; Klaus Lücke
Journal:  Int J Oncol       Date:  2012-07-16       Impact factor: 5.650

5.  Post-prandial endothelial dysfunction is ameliorated following weight loss in obese premenopausal women.

Authors:  Marcela Haspicova; David Milek; Michaela Siklova-Vitkova; Zuzana Wedellova; Jindriska Hejnova; Magda Bajzova; Vladimir Stich; Jan Polak
Journal:  Med Sci Monit       Date:  2011-11

6.  Are Physiologically Based Pharmacokinetic Models Reporting the Right C(max)? Central Venous Versus Peripheral Sampling Site.

Authors:  Helen Musther; Katherine L Gill; Manoranjenni Chetty; Amin Rostami-Hodjegan; Malcolm Rowland; Masoud Jamei
Journal:  AAPS J       Date:  2015-06-23       Impact factor: 4.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.